Endocyte Pops on Merck Deal
04/16/12 Endocyte shares posted a triple-digit percentage gain after entering into an agreement with Merck & Co. The development deal for Endocyte's experimental cancer drug could bring an additional $880 million to the biopharmaceutical company in m
Related Videos
Most Popular Videos
Latest Videos
Most Active by Volume:
| Company | Last Sale | Change Net / % |
|---|---|---|
| BAC | $ 13.5301 |
0.10  0.75%
|
| RAD | $ 2.90 |
0.11 3.94%
|
| WCRX | $ 19.66 |
0.45 2.34%
|
| CSCO | $ 23.9165 |
0.32  1.33%
|
| SIRI | $ 3.51 |
0.01 0.29%
|
| MSFT | $ 34.987 |
0.12 0.34%
|
| FB | $ 25.75 |
0.50 1.90%
|
| AMD | $ 4.11 |
0.04 0.98%
|
Latest News Headlines
UPDATE: Citi Names New CEOs of CitiMortgage, Private Bank, Citi Holdings 3:21PM ET - Dow Jones Business News
City National Opens New Branch in Pleasanton 3:20PM ET - GlobeNewswire
Correction to Plains Exploration Merger Story 3:17PM ET - Dow Jones Business News
Royalty Pharma Raises Takeover Bid for Elan 3:15PM ET - Dow Jones Business News
Liberty Global Puts Chellomedia Up For Sale 3:15PM ET - Dow Jones Business News